Guy Geldhof
Partner @ Vesalius Biocapital Partners
Strassen, Luxembourg
Guy Geldhof is a seed investor at Vesalius Biocapital Partners in Strassen focused on Health Care and Medical. Guy Geldhof has a Master’s degree in commercial engineering from the Free University of Brussels.He is a recognized business consultant and finance specialist. Guy started his career in 1991 with Arthur Andersen as member of the business advisory and audit team. He audited a large number of medium-sized and large companies. In 1995, he joinedAndersen’s business consulting team in Houston and, later, in Brussels. As a consultant, he was a generalist who grew into the function of director of the Strategy, Finance and Economics Service Team. Throughout his career Guy has been very active in the healthcare industry where he gained broad experience.In 2000, he was a co-founder of Value4Growth, a specialized consulting and management firm to support technology and life science companies. He has been a venture coach for many young companies and has supported these in all aspects of company formation, product strategy and fund raising. He has acted as CFO, external as well as internal, for young and fast-growing companies backed by VC funds.Since 2007, Guy also holds the position of Secretary General of the BVA, the Belgian Venture Capital and Private Equity Association.Guy joined Vesalius Biocapital as CFO in 2009. In January 2011, once the second Vesalius Biocapital fund has been created, he became Partner.During his career Guy has worked in the US and in several Western European countries.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 80%
Last updated:
For AI agents: llms.txt
Industries Guy Geldhof invests in
Stages Guy Geldhof invests in
Countries Guy Geldhof invests in
Investment Focus
Industry
- Health Care 2 (40%)
- Medical 1 (20%)
- Database 1 (20%)
- Hospital 1 (20%)
- Mobile Apps 1 (20%)
Stage
- Seed 1 (20%)
- Series A 1 (20%)
- Series B 1 (20%)
- Funding Round 1 (20%)
Country
- Belgium 1 (20%)
- Portugal 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tonic App
|
Tonic App is a B2C2B digital health company building a professional ecosystem for medical doctors. Tonic App helps medical doctors to diagnose and treat their patients by curating, for them, in a single mobile platform, the best professional resources from peers, publishers, regulatory bodies, recruiters, providers & the industry. | $11.8M / Series A / Mar 26, 2024 | |
OncoDNA
|
OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology. | $20.6M / Series B / Feb 14, 2020 | |
|
Tonic App
|
Tonic App is a B2C2B digital health company building a professional ecosystem for medical doctors. Tonic App helps medical doctors to diagnose and treat their patients by curating, for them, in a single mobile platform, the best professional resources from peers, publishers, regulatory bodies, recruiters, providers & the industry. | $3.7M / Aug 27, 2019 | |
|
Tonic App
|
Tonic App is a B2C2B digital health company building a professional ecosystem for medical doctors. Tonic App helps medical doctors to diagnose and treat their patients by curating, for them, in a single mobile platform, the best professional resources from peers, publishers, regulatory bodies, recruiters, providers & the industry. | $3.8M / Series A / Aug 27, 2019 | |
|
Tonic App
|
Tonic App is a B2C2B digital health company building a professional ecosystem for medical doctors. Tonic App helps medical doctors to diagnose and treat their patients by curating, for them, in a single mobile platform, the best professional resources from peers, publishers, regulatory bodies, recruiters, providers & the industry. | $3.8M / Seed / Aug 27, 2019 |
Co-Investors
About Vesalius Biocapital Partners
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Vesalius Biocapital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Fei Tian
Analyst
|
|||
|
Guy Geldhof
Partner
|
|||
Stephane Verdood
Managing Partner
|
|||
Alain Parthoens
Managing Partner
|
|||
Christian Schneider
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Guy Geldhof invest in?
Guy Geldhof invests primarily in Health Care, Medical and Database startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Guy Geldhof last invest?
The most recent investment recorded for Guy Geldhof closed in Mar 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
